Using Demographic Predictions, UW Prof Expounds Upon Trends in Tech
Madison, Wis. -- Paul Voss looks at the future in terms of social, not technological, change, but his demographic predictions could reveal upcoming trends in the technology needed by certain segments of the population.
The professor of rural sociology from the University of Wisconsin-Madison add...
UW prof makes laser for scanning lots of information at once
Madison University of Wisconsin-Madison researcher Scott Sanders has discovered a way to make a laser shine in not one but a rainbow of colors, and to deliver the colors one at a time so they can be used for scanning objects.
Researchers can derive information about a material based on its se...
UW prof turns sugar into diesel fuel, chemicals
Madison, Wis - The soaring prices of oil and natural gas have sparked a race to make transportation fuels from plant matter instead of petroleum, and both biodiesel and gasoline containing ethanol are starting to make an impact on the market.
But the oil price hike has also fueled a race to f...
A*STAR scientists invent the world's only controllable molecule gear of minuscule size of 1.2nm
...ls 3 ,
one of the most prestigious journals in materials science.
Joachim, "Making a gear the size of a few atoms is one thing,
but being abl...ore complex molecular
machines that are no bigger than a grain of sand."
Joachim and his team discovered that the way to successfully
control the ro...
SHARE Program Launched to Address the Challenges of Achieving Blood Pressure Goal
...ed life years (DALYs)
being attributed to the long-term effects of hypertension(2), with an annual
cardiovascular health bill of 192b Euros(3).
StÃ©phane Laurent, European Hospital Georges Pompidou Paris, program
co-chair, states, "The SHARE program is an excellent example of what can be
Nanostructure boosts efficiency in energy transport
...apturing energy within semiconductor materials and then efficiently transporting charges ultimately used to generate hydrogen.
Boston College Asst. prof
of Chemistry Dunwei Wang and members of his lab found that incorporating two titanium-based semiconductors into a nano-scale structure improved the ef...
Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain
...h means that oseltamivir will be
active against the vast majority of influenza infections in Europe this
season, if current trends continue," comments prof
Albert Osterhaus, Head of
Virology, Erasmus Medical Centre, Rotterdam. "It is important that doctors
understand that oseltamivir remains an effective ...
Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman
... Director for Biomedical Material Sciences in the Institute for
Biomedical Engineering and the Department of Materials at Imperial College,
London and prof
Robert Hill and Dr Julian Jones, of the Department of
Materials at Imperial College.
Based on their work, BCT is developing two generations of produ...
NTU and SIMTech announce the first antenna-in-package solution for single-chip 60 GHz radio
...sfer using wireless USB.
The team behind this project, comprising Assoc prof
Zhang Yue Ping, Dr Sun Mei of NTU, and Mr Chua Kai Meng, and Ms Wai Lai Lai...h interested industry partners to commercialise this invention," says Assoc prof
Zhang, principal investigator from NTU.
Kelly Osbourne and International Health Groups Call for Improved Education on Choices and Usage of Contraception
...ng and educate people
on their right to contraception and on how to use contraception properly to
prevent conception in the first instance," commented prof
from the European Society of Contraception and Reproductive Health (ESC).
"Unplanned pregnancies not only impact on society but most ...
Graphene pioneers follow in Nobel footsteps
...tter Division in Rome.
Aside from the prestige, prof
Geim and Dr Novoselov will share a cash prize of E...,000.
Since the discovery of graphene in 2004, prof
Geim and Dr Novoselov have published numerous rese...n detect just a single molecule of a toxic gas.
Geim said: "To receive this award is a great honou...
With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
presentation, the Chairman of the BEAUTIFUL Executive Committee, prof
Fox said, "Ivabradine was always known to relieve ischemia. With the
BE...ar drugs. Commenting on the results the Chairman of
the Steering Committee, prof
Roberto Ferrari said, "Often a lot of
investigations are performed in coron...
Graphene-based gadgets may be just years away
...thin films. We believe graphene should improve the durability and simplify the technology of potential electronic devices that interact with light.
Geim said: Transparent conducting films are an essential part of many gadgets including common liquid crystal displays (LCDs) for computers, TVs and m...
DuoCort Hosts Adrenal Insufficiency Symposium at the 10th European Congress of Endocrinology in Berlin
...l 7. All delegates attending ECE 2008 are invited to the symposium.
emer Michael Besser will chair the symposium, which also features a number of other authorities in the field: Dr John Newell-Price, prof
Brian R Walker, and Dr Gudmundur Johannsson, Chief Medical Officer of DuoCo...
Graphene gazing gives glimpse of foundations of universe
...c waves and its exact value is close to 1/137.
Geim, who in 2004 discovered graphene with Dr Kost...ecial conditions.
With large membranes in hand, prof
Geim says it requires barely anything more sophist...f our universe just looking through graphene, said prof
Graphene continues to surprise beyond the...
ThromboGenics Announces 2007 Full Year Results
...ising that the Company completed in May 2007.
- The Group streamlined its organization with the absorption of the
fully owned subsidiary Thromb-X.
Desire Collen, CEO of ThromboGenics, commenting on today's
announcement, said: "I am very pleased with what we have achieved during
the course of 2007...
ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
...SE-223 70 LUND Tel: +46(0)46-286-85-50 firstname.lastname@example.org
For further information please contact:
Desire Collen, CEO Tel: +32(0)16-34-61-94 email@example.com
Dr. Patrik De Haes, COO Tel: +32(0)16-34-61-94 patrik.dehaes@thromb...
Carbon offset warning from international team of scientists
...aland, The Netherlands, India, Germany and the UK. The UK is represented by prof
Andrew Watson of the University of East Anglia and Dr Richard Lampitt of Southampton Universitys National Oceanography Centre.
Watson said: While we do envision the possibility of iron fertilisation as ...
ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
...Nico van Rooijen, Stephane Plaisance, Mauro Giacca, Mieke
Dewerchin, Lieve Moons, JeanMarie Stassen, Desire Collen & Peter Carmeliet. ThromboGenics, prof
Désiré Collen, CEO, Patrik De Haes, COO, Tel: +32(0)16-34-61-94
BioInvent, Svein Mathisen, President & CEO, Tel: +46(0)46-286-85-67, Mob: +46(0...
Using nanotech to make Robocops
... thats why the engineers in Sydney have undertaken experiments to find the optimum point of elasticity for the most effective bullet-bouncing gear.
Liangchi Zhang and Dr Kausala Mylvaganam from the Centre for Advanced Materials Technology in Sydney, said, By investigating the force-repelling prope...
Top Spin Appoints Yaron Tal President and Chief Executive Officer, Erez Golan, TopSpin Medical's Founder and Current Chief Executive Officer, Will Continue as a Board Member and Consultant
...he investment arm of
Elron Electronic Industries Ltd and Discount investments Corporation Ltd.
Mr. Tal began his professional career in the offices of prof
. Swary -
Itzhak Swary & Co financial consulting - and has since accumulated
significant experience in mergers and acquisitions. Mr. Golan, TopSpin's...
Arpida Interim Results for six Months to 30 June 2007
...ttee consists of
Prof Dr Axel Kleemann (chair) and prof
Dr Nam-Hai Chua. The task of the
Commercialisation...ittees have been merged into one
which consists of prof
Dr Nam-Hai Chua (chair), Dr Andre Lamotte and Dr
H...mmittee consists of Dr Hans
Funfschilling (chair), prof
Dr Axel Kleemann and Michel Pettigrew, MBA. (Pre-...
ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
...raising that the company completed in May 2007. - The Group streamlined its organization with the absorption of the
fully owned subsidiary Thromb-X. prof
Desire Collen, CEO of ThromboGenics, commenting on today's
announcement, said: "I am very pleased with the all-round progress that we
have made during...